Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice

  • Shikha Jain
  • Prachiti Afley
  • Subodh Kumar
Original Paper


Brucellosis is a worldwide zoonotic disease. No Brucella vaccine is available for use in humans, and existing animal vaccines have limitations. There is a need to develop a safe and effective vaccine against human and animal brucellosis. In the present study, we generated recombinant cysteine synthase A (rCysK) of Brucella abortus in Escherichia coli and purified it up to homogeneity by metal affinity chromatography. The immunogenicity and protective efficacy of purified rCysK were evaluated in BALB/c mice with Freund’s adjuvant, aluminium hydroxide gel or without any adjuvant. High titres of anti-rCysK IgG antibody predominated by IgG1 were observed in all immunized mice. After stimulation with rCysK, the spleen lymphocytes of mice immunized with CysK formulated with aluminium hydroxide gel produced significant levels of IFN-γ. Protection against challenge with virulent B. abortus strain 544 was determined in BALB/c mice, and significant protection was observed in all CysK immunized groups when compared with PBS control. Among all the CysK vaccine groups, comparatively better protection was observed in mice immunized with aluminium hydroxide gel (1.064 units of protection). Overall, the results of the study suggest that rCysK induces primarily Th2 type of immune response and provides partial protection against B. abortus challenge.


Cysteine synthase A Brucella Subunit vaccine IFN-gamma 



The authors are thankful to Director, DRDE, for providing all facilities and support required for this study.


  1. Ackerley DF, Barak Y, Lynch SV, Curtin J, Matin A (2006) Effect of chromate stress on Escherichia coli K-12. J Bacteriol 188:3371–3381CrossRefGoogle Scholar
  2. Araya LN, Winter AJ (1990) Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun 58:254–256Google Scholar
  3. Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, Weyant R, Bragg SL, Spiegel RA, Tappero J, Perkins BA (2004) Adverse events in humans associated with accidental exposure to livestock brucellosis vaccine RB51. Vaccine 22:3435–3439CrossRefGoogle Scholar
  4. Baldwin CL, Goenka R (2006) Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 26:407–442CrossRefGoogle Scholar
  5. Blasco JM, Díaz R (1993) Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 342:805CrossRefGoogle Scholar
  6. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749–795CrossRefGoogle Scholar
  7. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA, DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6:3767–3780CrossRefGoogle Scholar
  8. Corbel MJ (1997a) Brucellosis: an overview. Emerg Infect Dis 3:213–221CrossRefGoogle Scholar
  9. Corbel MJ (1997b) Vaccines against bacterial zoonoses. J Med Microbiol 46:267–269CrossRefGoogle Scholar
  10. Eze MO, Yuan L, Crawford RM, Paranavitana CM, Hadfield TL, Bhattacharjee AK, Warren RL, Hoover DL (2000) Effects of opsonization and gamma interferon on growth of Brucella melitensis 16 M in mouse peritoneal macrophages in vitro. Infect Immun 68:257–263CrossRefGoogle Scholar
  11. Franco MP, Mulder M, Gilman RH, Smits HL (2007) Human brucellosis. Lancet Infect Dis 7:775–786CrossRefGoogle Scholar
  12. Hansson M, Nygren P, Stahl S (2000) Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 32:95–107CrossRefGoogle Scholar
  13. Jaques I, Cloeckaert A, Linet JN, Dubray G (1992) Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella. J Med Microbiol 37:100–103CrossRefGoogle Scholar
  14. Kumar S, Balakrishna K, Agarwal GS, Merwyn S, Rai GP, Batra HV, Sardesai AA, Gowrishankar J (2009) Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model. Antonie Van Leeuwenhoek 95:91–100CrossRefGoogle Scholar
  15. Liljeqvist S, Stahl S (1999) Production of recombinant subunit vaccine: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73:1–33CrossRefGoogle Scholar
  16. Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103:511–518CrossRefGoogle Scholar
  17. Noviello S, Gallo R, Kelly M, Limberger RJ, DeAngelis K, Cain L, Wallace B, Dumas N (2004) Laboratory-acquired brucellosis. Emerg Infect Dis 10:1848–1850CrossRefGoogle Scholar
  18. Oliveira SC, Harms JS, Rech EL, Rodarte RS, Bocca AL, Goes AM, Splitter GA (1998) The role of T cell subsets and cytokines in the regulation of an intracellular bacterial infection. Braz J Med Biol Res 32:77–84CrossRefGoogle Scholar
  19. Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005) Brucellosis. N Engl J Med 352:2325–2336CrossRefGoogle Scholar
  20. Pappas G, Panagopoulou P, Christou L, Akritidis N (2006a) Brucella as a biological weapon. Cell Mol Life Sci 63:2229–2236CrossRefGoogle Scholar
  21. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV (2006b) The new global map of human brucellosis. Lancet Infect Dis 6:91–99CrossRefGoogle Scholar
  22. Paranavitana C, Zelazowska E, Izadjoo M, Hoover D (2005) Interferon-γ associated cytokines and chemokines produced by spleen cells from Brucella-immune mice. Cytokine 30:86–92CrossRefGoogle Scholar
  23. Perkins SD, Smither SJ, Atkins HS (2010) Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34:379–394CrossRefGoogle Scholar
  24. Rafiei A, Ardestani SK, Kariminia A, Keyhani A, Mohraz M, Amirkhani A (2006) Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J Infect 53:315–324CrossRefGoogle Scholar
  25. Roitt J, Brostoff J, Male D (2001) Immunology. Mosby Publications, LondonGoogle Scholar
  26. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, Vol. 1, 3rd edn. CSHL press, New YorkGoogle Scholar
  27. Schurig GG, Roop RMII, Bagchi T, Boyle S, Buhrman D, Sriranganathan N (1991) Biological properties of RB51: a stable rough strain of Brucella abortus. Vet Microbiol 28:171–188CrossRefGoogle Scholar
  28. Schurig GG, Sriranganathan N, Corbel MJ (2002) Brucellosis vaccines: past, present and future. Vet Microbiol 90:479–496CrossRefGoogle Scholar
  29. Stevens MG, Hennager SG, Olsen SC, Cheville NF (1994) Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J Clin Microbiol 32:1065–1066Google Scholar
  30. Stevens MG, Olsen SC, Cheville NF (1995) Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or RB51. Vet Immunol Immunopathol 44:223–235CrossRefGoogle Scholar
  31. Tanous C, Soutourina O, Raynal B, Hullo MF, Mervelet P, Gilles AM, Noirot P, Danchin A, England P, Martin-Verstraeteal I (2008) The CymR regulator in complex with the enzyme CysK controls cysteine metabolism in Bacillus subtilis. J Biol Chem 283:35551–35560CrossRefGoogle Scholar
  32. Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46:e131–e136CrossRefGoogle Scholar
  33. Wu R, Sun Z, Wu J, Meng H, Zhang H (2010) Effect of bile salts stress on protein synthesis of Lactobacillus casei Zhang revealed by 2-dimensional gel electrophoresis. J Dairy Sci 93:3858–3868Google Scholar
  34. Xiang Z, Todd T, Ku KP, Kovacic BL, Larson CB, Chen F, Hodges AP, Tian Y, Olenzek EA, Zhao B, Colby LA, Rush HG, Gilsdorf JR, Jourdian GW, He Y (2008) VIOLIN: vaccine investigation and online information network. Nucleic Acids Res 36:D923–D928CrossRefGoogle Scholar
  35. Young EJ (1994) An overview of human brucellosis. Clin Infect Dis 21:283–289CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  1. 1.Division of MicrobiologyDefence Research and Development EstablishmentGwaliorIndia

Personalised recommendations